Contact
Please use this form to send email to PR contact of this press release:
Human medicines European public assessment report (EPAR): Blenrep, belantamab mafodotin, Multiple Myeloma, Date of authorisation: 25/08/2020, Revision: 6, Status: Authorised
TO: